Lyka Labs Limited (LYKALABS) Share Price
NSE · Healthcare · Biotechnology · ISIN INE933A01014
Key metrics
- Market Cap
- ₹267 Cr
- P/E Ratio
- —
- EPS
- -2.49
- Book Value
- 25.45
- P/B Ratio
- 2.9
- ROE
- -11.04%
- ROCE
- -8.67%
- Debt / Equity
- 0.54
- Net Margin
- -7.81%
- Revenue Growth
- -7.26%
- Profit Growth
- -225.21%
- Dividend Yield
- —
- 52W High
- ₹102.55
- 52W Low
- ₹44.10
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Lyka Labs Limited
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 499
- Promoter Holding
- 59.94%
The full Lyka Labs Limited analysis
Create a free account to open the complete LYKALABS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.